Therapeutic choices in patients with Ph-positive CML living in Mexico in the tyrosine kinase inhibitor era: SCT or TKIs?

Authors

Keywords

Journal

Volume 42, Issue 1, Pages 23-28

Publisher

Springer Nature

Online

2008-07-09

DOI

10.1038/bmt.2008.90

Discuss science. Find collaborators. Network.

Join a conversation

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now